Cleo Diagnostics Requests Trading Halt
Key points
- Company requests trading halt pending announcement on material capital raise
- Halt to remain until earlier of market open on Dec 19 or announcement release
- Company expects to make announcement before market open on Dec 19
Full summary
Cleo Diagnostics Ltd (ASX: COV) has requested a trading halt in its shares pending an announcement to the market in connection with a material capital raise. The trading halt has been requested to assist the company in managing its continuous disclosure obligations. The halt will remain in place until the earlier of the commencement of normal trading on Friday, 19 December 2025, or the release of the announcement regarding the capital raise. The company expects to make the announcement to the market before the commencement of normal trading on Friday, 19 December 2025. Cleo Diagnostics is not aware of any reason why the trading halt should not be granted or of any further information necessary to inform the market about the trading halt.
Summary generated by a large language model. Please interpret with care.